Quatramer&#8482; encapsulation of dual-targeted PI3-KÎ´/HDAC6 inhibitor, HSB-510, suppresses growth of breast cancer.

Tiwari, Sachchidanand; Liu, Suiyang; Anees, Mohd; Mehrotra, Neha; Thakur, Ashish; Tawa, Gregory J; Grewal, Gurmit; Stone, Richard; Kharbanda, Surender; Singh, Harpal

Quatramer™ encapsulation of dual-targeted PI3-KÎ´/HDAC6 inhibitor, HSB-510, suppresses growth of breast cancer.

Tiwari, Sachchidanand; Liu, Suiyang; Anees, Mohd; Mehrotra, Neha; Thakur, Ashish; Tawa, Gregory J; Grewal, Gurmit; Stone, Richard; Kharbanda, Surender; Singh, Harpal.

Afiliação

Tiwari S; Centre for Biomedical Engineering Indian Institute of Technology Delhi New Delhi India.
Liu S; Dana Farber Cancer Institute, Harvard Medical School Boston Massachusetts USA.
Anees M; Centre for Biomedical Engineering Indian Institute of Technology Delhi New Delhi India.
Mehrotra N; Centre for Biomedical Engineering Indian Institute of Technology Delhi New Delhi India.
Thakur A; National Center for Advancing Translational Sciences National Institutes of Health Rockville Maryland USA.
Tawa GJ; National Center for Advancing Translational Sciences National Institutes of Health Rockville Maryland USA.
Grewal G; National Center for Advancing Translational Sciences National Institutes of Health Rockville Maryland USA.
Stone R; Dana Farber Cancer Institute, Harvard Medical School Boston Massachusetts USA.
Kharbanda S; Dana Farber Cancer Institute, Harvard Medical School Boston Massachusetts USA.
Singh H; Centre for Biomedical Engineering Indian Institute of Technology Delhi New Delhi India.

Bioeng Transl Med ; 8(5): e10541, 2023 Sep.

Article em En | MEDLINE | ID: mdl-37693068

Palavras-chave

HDAC6; Nanoformulation; PI3KÎ´; PLA; breast cancer

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Bioeng Transl Med Ano de publicação: 2023 Tipo de documento: Article